STATCenter·
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Read at STAT →
Health · 1 sources covering this
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/4417c806fbcce1f0969dbc64ddc5ad2706e7501f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua"></iframe>
